A theoretical approach to the problem of dose-volume constraint estimation and their impact on the dose-volume histogram selection

Medical Physics

Volumn 33, Issue 9, 2006, Pages 3444-3459

  Schinkel, Colleen ^a,b   Stavrev, Pavel ^b   Stavreva, Nadia ^b   Fallone, B Gino ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Biological optimization; Dose volume constraints; DVH; Inverse planning; NTCP; Physical optimization

Indexed keywords

GRAPHIC METHODS;

DOSE-VOLUME; DOSE-VOLUME HISTOGRAMS; INVERSE PLANNING; NORMAL TISSUE COMPLICATION PROBABILITIES; NTCP; PHYSICAL OBJECTIVE FUNCTIONS; RADIATION TREATMENTS; THEORETICAL APPROACH;

MAXIMUM LIKELIHOOD ESTIMATION;

ARTICLE; DOSE CALCULATION; HISTOGRAM; MAXIMUM PERMISSIBLE DOSE; MEDICAL RESEARCH; PRIORITY JOURNAL; RADIATION DOSE;

EID: 33748331397     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2237453     Document Type: Article

References (61)

1. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin, and M. Wesson, "Tolerance of normal tissue to therapeutic irradiation," Int. J. Radiat. Oncol., Biol., Phys. 21, 109-122 (1991).
2. A. Niemierko, M. Urie, and M. Goitein, "Optimization of 3D radiation therapy with both physical and biological end points and constraints," Int. J. Radiat. Oncol., Biol., Phys. 23, 99-108 (1992).
3. W. R. De Gersem, S. Derycke, C. O. Colle, C. De Wagter, and W. J. De Neve, "Inhomogeneous target-dose distributions: A dimension more for optimization?," Int. J. Radiat. Oncol., Biol., Phys. 44, 461-468 (1999).
4. W. R. De Gersem, S. Derycke, C. De Wagter, and W. C. De Neve, "Optimization of beam weights in conformal radiotherapy planning of stage III non-small cell lung cancer: Effects on therapeutic ratio," Int. J. Radiat. Oncol., Biol., Phys. 47, 255-260 (2000).
5. G. O. De Meerleer, L. A. Vakaet, W. R. De Gersem, C. De Wagter, B. De Naeyer, and W. De Neve, "Radiotherapy of prostate cancer with or without intensity modulated beams: A planning comparison," Int. J. Radiat. Oncol., Biol., Phys. 47, 639-648 (2000).
6. P. Stavrev, D. Hristov, B. Warkentin, E. Sham, N. Stavreva, and B. G. Fallone, "Inverse treatment planning by physically constrained minimization of a biological objective function," Med. Phys. 30, 2948-2958. (2003).
7. A. Dritschilo, J. T. Chaffey, W. D. Bloomer, and A. Marck, "The complication probability factor: A method for selection of radiation treatment plans," Br. J. Radiol. 51, 370-374. (1978).
8. A. B. Wolbarst, E. S. Sternick, B. H. Curran, and A. Dritschilo, "Optimized radiotherapy treatment planning using the complication probability factor (cpf)," Int. J. Radiat. Oncol., Biol., Phys. 6, 723-728 (1980).
9. M. Zaider and H. I. Amols, "Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization," Int. J. Radiat. Oncol., Biol., Phys. 44, 439-447 (1999).
10. L. Cozzi, F. M. Buffa, and A. Fogliata, "Comparative analysis of dose volume histogram reduction algorithms for normal tissue complication probability calculations," Acta Oncol. 39, 165-171 (2000).
11. V. Moiseenko, J. Battista, and J. Van Dyk, "Normal tissue complication probabilities: Dependence on choice of biological model and dose-volume histogram reduction scheme," Int. J. Radiat. Oncol., Biol., Phys. 46, 983-993 (2000).
12. S. L. Kwa, J. V. Lebesque, J. C. Theuws, L. B. Marks, M. T. Munley, G. Bentel, D. Oetzel, U. Spahn, M. V. Graham, R. E. Drzymala, J. A. Purdy, A. S. Lichter, M. K. Martel, and R. K. Ten Haken, "Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients," Int. J. Radiat. Oncol., Biol., Phys. 42, 1-9 (1998).
13. M. K. Martel, W. M. Sahijdak, R. K. Ten Haken, M. L. Kessler, and A. T. Turrisi, "Fraction size and dose parameters related to the incidence of pericardial effusions," Int. J. Radiat. Oncol., Biol., Phys. 40, 155-161 (1998).
14. L. A. Dawson, R. K. Ten Haken, and T. S. Lawrence, "Partial irradiation of the liver," Semin. Radiat. Oncol. 11, 240-246 (2001).
15. A. Eisbruch, J. A. Ship, H. M. Kim, and R. K. Ten Haken, "Partial irradiation of the parotid gland," Semin. Radiat. Oncol. 11, 234-239 (2001).
16. G. Gagliardi, I. Lax, and L. E. Rutqvist, "Partial irradiation of the heart," Semin. Radiat. Oncol. 11, 224-233 (2001).
17. A. Jackson, "Partial irradiation of the rectum," Semin. Radiat. Oncol. 11, 215-223 (2001).
18. S. Levegrun, L. Ton, and J. Debus, "Partial irradiation of the brain," Semin. Radiat. Oncol. 11, 259-267 (2001).
19. T. E. Schultheiss, "The controversies and pitfalls in modeling normal tissue radiation injury/damage," Semin. Radiat. Oncol. 11, 210-214 (2001).
20. Y. Seppenwoolde and J. V. Lebesque, "Partial irradiation of the lung," Semin. Radiat. Oncol. 11, 247-258 (2001).
21. E. L. Travis, "Organizational response of normal tissues to irradiation," Semin. Radiat. Oncol. 11, 184-196 (2001).
22. E. D. Yorke, "Modeling the effects of inhomogeneous dose distributions in normal tissues," Semin. Radiat. Oncol. 11, 197-209 (2001).
23. J. C. Cheng, J. K. Wu, C. M. Huang, H. S. Liu, D. Y. Huang, S. H. Cheng, S. Y. Tsai, J. J. Jian, Y. M. Lin, T. I. Cheng, C. F. Horng, and A. T. Huang, "Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication," Int. J. Radiat. Oncol., Biol., Phys. 54, 156-162 (2002).
24. L. A. Dawson, D. Normolle, J. M. Balter, C. J. McGinn, T. S. Lawrence, and R. K. Ten Haken, "Analysis of radiation-induced liver disease using the Lyman NTCP model," Int. J. Radiat. Oncol., Biol., Phys. 53, 810-821 (2002).
25. V. Moiseenko, T. Craig, A. Bezjak, and J. Van Dyk, "Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: A retrospective review," Radiol. Oncol. 67, 265-274 (2003).
26. Y. Seppenwoolde, J. V. Lebesque, K. de Jaeger, J. S. Belderbos, L. J. Boersma, C. Schilstra, G. T. Henning, J. A. Hayman, M. K. Martel, and R. K. Ten Haken, "Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability," Int. J. Radiat. Oncol., Biol., Phys. 55, 724-735 (2003).
27. L. A. Dawson and R. K. Ten Haken, "Partial volume tolerance of the liver to radiation," Semin. Radiat. Oncol. 15, 279-283 (2005).
28. I. Tsougos, P. Mavroidis, J. Rajala, K. Theodorou, R. Jarvenpaa, M. A. Pitkanen, K. Holli, A. T. Ojala, B. K. Lind, S. Hyodynmaa, and C. Kappas, "Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy," Phys. Med. Biol. 50, 3535-3554 (2005).
29. J. D. Fenwick, V. S. Khoo, A. E. Nahum, B. Sanchez-Nieto, and D. P. Dearnaley, "Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 49, 473-480 (2001).
30. J. V. Lebesque, A. M. Bruce, A. P. Kroes, A. Touw, R. T. Shouman, and M. van Herk, "Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 33, 1109-1119 (1995).
31. J. Y. Ting, X. Wu, J. A. Fiedler, C. Yang, M. L. Watzich, and A. Markoe, "Dose-volume histograms for bladder and rectum," Int. J. Radiat. Oncol., Biol., Phys. 38, 1105-1111 (1997).
32. P. V. Stavrev, D. H. Hristov, and J. P. Seuntjens, "On the consistent use of organ definitions and radiobiological models for the evaluation of complication probabilities of "Tubular" Organs," Int. J. Radiat. Oncol., Biol., Phys. 52, 1150-1152 (2002).
33. P. Stavrev, N. Stavreva, D. Hristov, and B. Fallone, "Reverse mapping of normal tissue complication probabilities onto dose volume histogram space: Problem formulation, illustration, and implications," in Proceedings of World Congress on Medical Physics and Biomedical Engineering, Sydney, Australia 24-29 August 2003.
34. C. Burman, G. J. Kutcher, B. Emami, and M. Goitein, "Fitting of normal tissue tolerance data to an analytic function," Int. J. Radiat. Oncol., Biol., Phys. 21, 123-135 (1991).
35. P. Stavrev, N. Stavreva, A. Niemierko, and M. Goitein, "The application of biological models to clinical data," Phys. Medica 17, 71-82 (2001).
36. K. Markov, C. Schinkel, P. Stavrev, N. Stavreva, M. Weldon, and B. G. Fallone, "Reverse mapping of normal tissue complication probabilities onto dose volume histogram space: The problem of randomness of the dose volume histogram sampling," Med. Phys. 33, 3435-3443 (2006).
37. J. T. Lyman, "Complication probability as assessed from dose-volume histograms," Radiat. Res. Suppl. 8, S13-19 (1985).
38. P. Stavrev, D. Hristov, C. Field, and G. B. Fallone, "Fractionation correction to Lyman's model," Med. Phys. 29, 1248-1248 (2002).
39. D. R. Olsen, "The tissue volume effect: A reliability model," in Proceedings of the 9th Annual ESTRO Meeting, 1990.
40. A. Jackson, G. J. Kutcher, and E. D. Yorke, "Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation," Med. Phys. 20, 613-625 (1993).
41. A. Niemierko and M. Goitein, "Modeling of normal tissue response to radiation: The critical volume model," Int. J. Radiat. Oncol., Biol., Phys. 25, 135-145 (1993).
42. P. Stavrev, N. Stavreva, A. Niemierko, and M. Goitein, "Generalization of a model of tissue response to radiation based on the idea of functional subunits and binomial statistics," Phys. Med. Biol. 46, 1501-1518 (2001).
43. D. R. Olsen, B. K. Kambestad, and D. T. Kristoffersen, "Calculation of radiation induced complication probabilities for brain, liver and kidney, and the use of a reliability model to estimate critical volume fractions," Br. J. Radiol. 67, 1218-1225 (1994).
44. D. Hristov, P. Stavrev, E. Sham, and B. G. Fallone, "On the implementation of dose-volume objectives in gradient algorithms for inverse treatment planning," Med. Phys. 29, 848-856 (2002).
45. A. Niemierko, "Reporting and analyzing dose distributions: A concept of equivalent uniform dose," Med. Phys. 24, 103-110 (1997).
46. A. Niemierko and M. Goitein, "Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture," Radiol. Oncol. 20, 166-176 (1991).
47. A. Niemierko, "A generalized concept of equivalent uniform dose, 41th AAPM annual meeting, Nashville, July 24-29," Med. Phys. 26, 1100 (1999).
48. P. Stavrev, D. Hristov, and E. Sham, "IMRT inverse treatment planning optimization based on physical constraints and biological objectives," in Proceedings of the 47th Annual General Meeting of the Canadian Organization of Medical Physicists (COMP), Kelowna, British Columbia, Canada, 2001.
49. A. Jackson, R. K. Ten Haken, J. M. Robertson, M. L. Kessler, G. J. Kutcher, and T. S. Lawrence, "Analysis of clinical complication data for radiation hepatitis using a parallel architecture model," Int. J. Radiat. Oncol., Biol., Phys. 31, 883-891 (1995).
50. E. D. Yorke, A. Jackson, K. E. Rosenzweig, L. Braban, S. A. Leibel, and C. C. Ling, "Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study," Int. J. Radiat. Oncol., Biol., Phys. 63, 672-682 (2005).
51. H. R. Withers, J. M. Taylor, and B. Maciejewski, "Treatment volume and tissue tolerance," Int. J. Radiat. Oncol., Biol., Phys. 14, 751-759 (1988).
52. T. R. Mackie, J. Balog, K. Ruchala, D. Shepard, S. Aldridge, E. Fitchard, P. Reckwerdt, G. Olivera, T. McNutt, and M. Mehta, "Tomotherapy," Semin. Radiat. Oncol. 9, 108-117 (1999).
53. T. R. Mackie, T. Holmes, S. Swerdloff, P. Reckwerdt, J. O. Deasy, J. Yang, B. Paliwal, and T. Kinsella, "Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy," Med. Phys. 20, 1709-1719 (1993).
54. X. Wang, X. Zhang, L. Dong, H. Liu, Q. Wu, and R. Mohan, "Development of methods for beam angle optimization for IMRT using an accelerated exhaustive search strategy," Int. J. Radiat. Oncol., Biol., Phys. 60, 1325-1337 (2004).
55. M. M. Coselmon, J. M. Moran, J. D. Radawski, and B. A. Fraass, "Improving IMRT delivery efficiency using intensity limits during inverse planning," Med. Phys. 32, 1234-1245 (2005).
56. C. T. Lee, S. D. Bilton, R. M. Famiglietti, B. A. Riley, A. Mahajan, E. L. Chang, M. H. Maor, S. Y. Woo, J. D. Cox, and A. R. Smith, "Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: How do protons compare with other conformal techniques?," Int. J. Radiat. Oncol., Biol., Phys. 63, 362-372 (2005).
57. J. K. Horton, J. S. Halle, S. X. Chang, and C. I. Sartor, "Comparison of three concomitant boost techniques for early-stage breast cancer," Int. J. Radiat. Oncol., Biol., Phys. 64, 168-175 (2006).
58. A. C. Hartford, A. Niemierko, J. A. Adams, M. M. Urie, and W. U. Shipley, "Conformal irradiation of the prostate: Estimating long-term rectal bleeding risk using dose-volume histograms," Int. J. Radiat. Oncol., Biol., Phys. 36, 721-730 (1996).
59. E. H. Huang, A. Pollack, L. Levy, G. Starkschall, L. Dong, I. Rosen, and D. A. Kuban, "Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 54, 1314-1321 (2002).
60. A. Jackson, M. W. Skwarchuk, M. J. Zelefsky, D. M. Cowen, E. S. Venkatraman, S. Levegrun, C. M. Burman, G. J. Kutcher, Z. Fuks, S. A. Liebel, and C. C. Ling, "Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms," Int. J. Radiat. Oncol., Biol., Phys. 49, 685-698 (2001).
61. A. Pollack, G. K. Zagars, G. Starkschall, J. A. Antolak, J. J. Lee, E. Huang, A. C. von Eschenbach, D. A. Kuban, and I. Rosen, "Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial," Int. J. Radiat. Oncol., Biol., Phys. 53, 1097-1105 (2002).